http://www.fixthedebt.org/ - A recent report highlights the need to strengthen Social Security's finances. A new, interactive tool allows you to make the choices to preserve it for future generations.
Brock Beauty, Inc.’s bestselling hair vitamin Hairfinity® has been helping women grow healthier hair for more than 10 years. This Mother’s Day, founder Tai Lawrence is giving the world an intimate look into the inspiration behind the product – her daughter Jasmine – in a two minute short film called “They Learn From You.”
In “They Learn From You,” Tai describes her hair journey and shares her experience raising her daughter. “I struggled with my hair growing up. All of the chemicals, products and heat styling really did a number on the health of my hair,” said Tai Lawrence Brock Beauty Founder and visionary behind Hairfinity. “Most women have a childhood experience that defines their relationship with their hair. I wanted my little girl to feel good about her healthy hair and not be concerned about whether it was long, short, curly, textured or straight. That’s why Hairfinity® was created.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7522951-brock-beauty-hairfinity-hair-supplement/
EnteroMedics Inc. (NASDAQ: ETRM) today announced that the U.S. Food and Drug Administration (FDA) has approved VBLOC® vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients with obesity who have a Body Mass Index (BMI) of at least 40 to 45 kg/m2, or a BMI of at least 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels, and who have tried to lose weight in a supervised weight management program within the past five years. The Maestro System is the first new medical device to be approved by the FDA for obesity in over ten years. EnteroMedics anticipates that the device will be available, on a limited basis, at select Bariatric Centers of Excellence in the U.S. this year. The Maestro System has received CE Mark and is listed on the Australian Register of Therapeutic Goods.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7269351-enteromedics-fda-approval-vbloc-maestro-system-weight-loss-device/
Cantor Fitzgerald, a leading financial services firm, today announced that Cantor Fitzgerald, together with its affiliate BGC Partners, Inc., raised approximately $12 million for dozens of charities around the world, at the companies’ annual Charity Day on September 12, 2016. Each year, Cantor Fitzgerald and BGC Partners donate 100% of the global revenues generated on Charity Day to the Cantor Fitzgerald Relief Fund, and to date has raised approximately $137 million globally since its inception.
“We will never forget all of our friends and colleagues who perished on 9/11. Charity Day represents our company’s fundamental commitment to helping others, and allows us to commemorate the events of that day. Giving back is our way of remembering those who lost their lives on 9/11, turning a day of tragedy into a positive and uplifting day for our employees and friends,” said Howard W. Lutnick, Chairman and Chief Executive Officer of Cantor Fitzgerald, L.P. and BGC Partners.
To view the multimedia release go to:
http://www.multivu.com/players/English/7921552-cantor-fitzgerald-charity-day-2016/
Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, commemorated its 50-year anniversary by awarding $150,000 in total grants to three organizations that share its goal to improve healthcare: The American Red Cross, the National Ovarian Cancer Coalition and Autism Speaks.
At a ceremony at the company’s flagship clinical laboratory in Teterboro, NJ, the company’s chairman, president and CEO Steve Rusckowski presented Health In Your Hands grants of $50,000 to representatives from each organization. Paul Brown, M.D., founder and former CEO of Quest’s predecessor company Metropolitan Pathology Laboratory, Inc. or MetPath, established in April, 1967, was also recognized at the event.
To view the multimedia release go to:
https://www.multivu.com/players/English/8080751-quest-diagnostics-50th-anniversary/
Understanding the burden of metastatic breast cancer (MBC), and the toll it takes on patients and their loved ones, Eisai Inc. announced today the launch of mbcInfoCenter.com, a new online portal designed to provide important resources that may help women with MBC manage their disease and focus on their health and wellness.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7342251-eisai-launches-mbc-infocenter-for-women-with-metastatic-breast-cancer/
http://www.legalenglish.com/
Legal-Ease International offers classes ONLINE in Legal English for Foreign lawyers. Start your day with a morning online class with your coffee, Diploma and materials included. www.legalenglish.com/seminars/
The International Nut and Dried Fruit Council (INC) has celebrated the XXXV World Nut and Dried Fruit Congress in San Diego. From May 30th until today, more than 1,400 delegates have participated in the only and largest international event dedicated to the nut and dried fruit industry that this year’s edition has broken previous records of attendance.
The INC Congress featured a stimulating three-day program to exchange knowledge, ideas and experiences. Attendees had over 16 sessions, among round tables, seminars and keynote speakers’ presentations ranging in topics from market dynamics, crops and production forecasts, agricultural and water resources, new findings in health and nutrition, and product innovations.
Steve Junqueiro, Co-president and COO of Save Mart Supermarkets, shared his vision on the future of American supermarkets. He outlined a market featured by a more digital consumer driven by food transparency, convenience, connectivity, emotional connection and local and sustainable supply.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7849351-inc-world-nut-dried-fruit-congress/
TransCelerate BioPharma Inc., a non-profit organization dedicated to improving the health of people around the world by simplifying and accelerating research and development of innovative new therapies, has unveiled a new global campaign designed to help increase awareness of the growing need for clinical trial participants. The campaign, called “One Person Closer,” focuses on inspiring healthcare professionals (HCPs) to consider clinical research as a possibility for their patients, incorporate the topic into their daily practices, and have meaningful conversations with patients about opportunities to participate in clinical trials.
One Person Closer is designed to put a human face on research and development by sharing the personal stories of researchers, HCPs and patients who have contributed to clinical research and the development of medical breakthroughs. The photojournalist campaign aims to show doctors, nurses and other HCPs that they can help facilitate research that advances science and that may benefit their patients.
To view the multimedia release go to:
https://www.multivu.com/players/English/8268751-transcelerate-biopharma-one-person-closer/
Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Inspire Upper Airway Stimulation (UAS) therapy for use in a subset of patients with moderate to severe Obstructive Sleep Apnea (OSA) who are unable to use Continuous Positive Airway Pressure (CPAP). Inspire therapy is a fully implanted neurostimulation device, the first of its kind for sleep apnea, that provides an alternative treatment that is proven, convenient and easy to use.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7169651-fda-approves-inspire-upper-airway-stimulation-therapy-sleep-apnea
